Okay, let's tackle this question. The patient has a very high platelet count—700 x 10^9/L. That's thrombocytosis. The options aren't listed, but the correct answer is probably a myeloproliferative disorder. The key here is the presence of abnormal platelet morphology and absence of the Philadelphia chromosome.

First, essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by elevated platelet counts, often with morphological abnormalities. The absence of Philadelphia chromosome rules out CML, which is associated with that chromosomal abnormality (t(9;22)). CML typically presents with elevated WBC and Philadelphia chromosome.

The patient's WBC is 12 x 10^9/L, which is slightly elevated but not as high as seen in CML. The hemoglobin is 11g/dl, which is mild anemia, but not specific. The main differentials here would be between ET, polycythemia vera (PV), and other MPNs. PV usually has elevated RBC counts and the JAK2 mutation, but the platelet count might be normal or elevated. The absence of Philadelphia chromosome also rules out CML.

Other options like reactive thrombocytosis (post-infection, inflammation) would not typically have platelet morphology changes. The presence of abnormal platelets suggests a clonal disorder. So, the most likely diagnosis is essential thrombocythemia. The clinical pearl here is that ET is diagnosed when there's a persistently elevated platelet count with no reactive cause, and absence of other MPN features. The correct answer should be ET.

**Core Concept**
This question tests the diagnosis of myeloproliferative neoplasms (MPNs), particularly **essential thrombocythemia (ET)**, based on thrombocytosis with abnormal platelet morphology and exclusion of other MPNs like CML via Philadelphia chromosome absence.

**Why the Correct Answer is Right**
The patient has **thrombocytosis (>600 x 10⁹/L)** with **dysmorphic platelets** (size/shape/granularity changes), **mild leukocytosis (12 x 10⁹/L)**, and **no Philadelphia chromosome**. ET is a clonal MPN driven by mutations in **JAK2**, **CALR**, or **MPL** genes, leading to autonomous megakaryocyte proliferation. The absence of Philadelphia chromosome (seen in CML) and lack of splenomegaly or other MPN features (like polycythemia vera) support ET. Abnormal platelets are a hallmark due to dysregulated maturation.

**Why Each Wrong Option is Incorrect**
**Option A:** *Chronic Myeloid Leukemia (CML)* is incorrect because it is associated with the Philadelphia chromosome (*t(9;22)*), which is absent here. CML also presents with a much higher WBC (often >50 x 10⁹/L).
**Option B:** *Reactive Thrombocytosis* is incorrect because it occurs due to inflammation or infection and does not cause platelet morphology changes.
**Option C:** *Polycythemia Vera* is

✓ Correct Answer: B. Essential thrombocythemia